Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
8.94
-0.06 (-0.70%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $618.72 million as of October 23, 2024. Its market cap has decreased by -23.22% in one year.
Market Cap
618.72M
Enterprise Value
580.07M
1-Year Change
-23.22%
Ranking
Category
Stock Price
$8.94
Market Cap Chart
Since December 23, 2020, Pharming Group's market cap has decreased from $1.07B to $618.72M, a decrease of -41.94%. That is a compound annual growth rate of -13.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 604.40M | -19.78% |
| Dec 29, 2023 | 753.40M | 5.28% |
| Dec 30, 2022 | 715.60M | 25.30% |
| Dec 31, 2021 | 571.10M | -41.09% |
| Dec 31, 2020 | 969.50M | -9.02% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Astria Therapeutics | 626.32M |
| CureVac | 619.11M |
| Orthofix Medical | 614.42M |
| Terns Pharmaceuticals | 609.63M |
| Acelyrin | 603.84M |
| Entrada Therapeutics | 593.43M |
| Allogene Therapeutics | 590.74M |
| Fulgent Genetics | 588.66M |